COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Fecal Microbiota Transplant (FMT) in Melanoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03341143
Recruitment Status : Suspended (Study suspended due to COVID 19. Study recruitment estimated to resume by September, 2020.)
First Posted : November 14, 2017
Last Update Posted : July 23, 2020
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Diwakar Davar, University of Pittsburgh

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : July 2021